GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.59
-0.32 (-0.46%)
At close: Aug 6, 2026, 4:00 PM EDT
68.13
-1.46 (-2.10%)
Pre-market: Aug 7, 2026, 8:04 AM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.08 billion as of August 7, 2026. Its market cap has decreased by -32.26% in one year.
Market Cap
2.08B
Enterprise Value
2.11B
1-Year Change
-32.26%
Ranking
Category
Stock Price
$69.59
ChartMarket Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.08B, a decrease of -88.40%. That is a compound annual growth rate of -31.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 2.08B | -44.79% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RadNet | 5.25B |
| Sotera Health Company | 5.13B |
| Adaptive Biotechnologies | 3.68B |
| Veracyte | 3.61B |
| GRAIL | 3.02B |
| CareDx | 2.48B |
| NeoGenomics | 2.04B |
| Personalis | 1.38B |